 Colleen McIlvennan
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 59 | 2024 | 550 | 12.210 |
Why?
| | Heart Failure | 82 | 2025 | 2222 | 9.360 |
Why?
| | Caregivers | 26 | 2024 | 872 | 4.880 |
Why?
| | Terminal Care | 10 | 2022 | 224 | 2.160 |
Why?
| | Decision Making | 15 | 2023 | 906 | 2.100 |
Why?
| | Palliative Care | 10 | 2024 | 738 | 1.650 |
Why?
| | Heart Transplantation | 8 | 2024 | 749 | 1.570 |
Why?
| | Quality of Life | 22 | 2024 | 2870 | 1.520 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 540 | 1.100 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 389 | 1.020 |
Why?
| | Choice Behavior | 2 | 2020 | 174 | 1.000 |
Why?
| | Delivery of Health Care | 4 | 2023 | 948 | 0.960 |
Why?
| | Patient Care Team | 5 | 2024 | 629 | 0.950 |
Why?
| | Cardiology | 2 | 2019 | 279 | 0.950 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2024 | 1332 | 0.940 |
Why?
| | Humans | 102 | 2025 | 137514 | 0.870 |
Why?
| | Thrombosis | 3 | 2021 | 368 | 0.860 |
Why?
| | Heart Injuries | 1 | 2023 | 37 | 0.800 |
Why?
| | Physician-Patient Relations | 4 | 2024 | 552 | 0.790 |
Why?
| | Stress, Psychological | 3 | 2021 | 1115 | 0.790 |
Why?
| | Patient Participation | 7 | 2025 | 423 | 0.770 |
Why?
| | Registries | 6 | 2024 | 2021 | 0.760 |
Why?
| | Emotions | 6 | 2023 | 590 | 0.760 |
Why?
| | Middle Aged | 41 | 2025 | 33355 | 0.720 |
Why?
| | Patients | 3 | 2023 | 175 | 0.700 |
Why?
| | Substance Abuse Detection | 2 | 2025 | 90 | 0.690 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 153 | 0.670 |
Why?
| | Palliative Medicine | 2 | 2017 | 15 | 0.660 |
Why?
| | Patient Preference | 6 | 2024 | 190 | 0.660 |
Why?
| | Health Literacy | 3 | 2024 | 169 | 0.650 |
Why?
| | Delirium | 1 | 2021 | 85 | 0.650 |
Why?
| | Patient Readmission | 2 | 2015 | 696 | 0.620 |
Why?
| | Biomedical Research | 3 | 2020 | 689 | 0.610 |
Why?
| | Attitude to Death | 2 | 2016 | 69 | 0.600 |
Why?
| | Aged | 32 | 2025 | 23798 | 0.590 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 368 | 0.590 |
Why?
| | Coronavirus Infections | 2 | 2020 | 359 | 0.580 |
Why?
| | Risk Assessment | 6 | 2020 | 3439 | 0.580 |
Why?
| | Betacoronavirus | 2 | 2020 | 268 | 0.580 |
Why?
| | Qualitative Research | 9 | 2024 | 1361 | 0.570 |
Why?
| | Male | 49 | 2025 | 67718 | 0.570 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 809 | 0.560 |
Why?
| | Hospice Care | 3 | 2016 | 201 | 0.550 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 18 | 0.540 |
Why?
| | Female | 49 | 2025 | 73162 | 0.540 |
Why?
| | Surveys and Questionnaires | 9 | 2024 | 5772 | 0.540 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 19 | 0.520 |
Why?
| | Hospital Records | 1 | 2016 | 12 | 0.520 |
Why?
| | Mexiletine | 1 | 2016 | 6 | 0.510 |
Why?
| | Amphetamine | 1 | 2016 | 34 | 0.510 |
Why?
| | Hospitalization | 5 | 2024 | 2197 | 0.510 |
Why?
| | Quality Improvement | 4 | 2021 | 1161 | 0.510 |
Why?
| | Physicians | 4 | 2020 | 904 | 0.490 |
Why?
| | Adaptation, Psychological | 9 | 2024 | 653 | 0.490 |
Why?
| | Bereavement | 1 | 2016 | 54 | 0.480 |
Why?
| | Myocardial Infarction | 1 | 2023 | 1045 | 0.480 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 321 | 0.480 |
Why?
| | Cryosurgery | 1 | 2016 | 59 | 0.480 |
Why?
| | Transplant Recipients | 1 | 2016 | 180 | 0.460 |
Why?
| | Drug Monitoring | 1 | 2016 | 221 | 0.450 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 57 | 0.450 |
Why?
| | Patient-Centered Care | 4 | 2021 | 527 | 0.450 |
Why?
| | Heart Diseases | 2 | 2017 | 359 | 0.440 |
Why?
| | Adult | 29 | 2025 | 37821 | 0.440 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 174 | 0.440 |
Why?
| | Depression | 2 | 2021 | 1408 | 0.440 |
Why?
| | Heart Ventricles | 4 | 2021 | 792 | 0.430 |
Why?
| | Advance Care Planning | 2 | 2017 | 202 | 0.430 |
Why?
| | Treatment Outcome | 13 | 2024 | 10821 | 0.430 |
Why?
| | Stroke Volume | 4 | 2023 | 619 | 0.420 |
Why?
| | Decision Support Techniques | 4 | 2020 | 419 | 0.410 |
Why?
| | Research Design | 1 | 2019 | 1116 | 0.400 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1465 | 0.400 |
Why?
| | Substance-Related Disorders | 2 | 2025 | 1079 | 0.400 |
Why?
| | United States | 18 | 2025 | 14696 | 0.400 |
Why?
| | Blood Coagulation | 1 | 2014 | 254 | 0.390 |
Why?
| | Informed Consent | 1 | 2014 | 170 | 0.390 |
Why?
| | Attitude to Health | 1 | 2016 | 444 | 0.390 |
Why?
| | Pandemics | 2 | 2020 | 1619 | 0.390 |
Why?
| | Interviews as Topic | 4 | 2024 | 767 | 0.380 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1286 | 0.370 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2113 | 0.360 |
Why?
| | Anticoagulants | 2 | 2021 | 665 | 0.350 |
Why?
| | American Heart Association | 4 | 2024 | 306 | 0.340 |
Why?
| | Activities of Daily Living | 1 | 2014 | 414 | 0.330 |
Why?
| | Health Personnel | 2 | 2022 | 699 | 0.330 |
Why?
| | Program Development | 2 | 2023 | 366 | 0.290 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 403 | 0.280 |
Why?
| | Social Support | 3 | 2024 | 616 | 0.280 |
Why?
| | Patient Education as Topic | 3 | 2018 | 766 | 0.270 |
Why?
| | Risk Factors | 9 | 2021 | 10356 | 0.250 |
Why?
| | Withholding Treatment | 2 | 2016 | 76 | 0.240 |
Why?
| | Mental Health | 2 | 2023 | 724 | 0.240 |
Why?
| | Communication | 4 | 2024 | 874 | 0.240 |
Why?
| | Cost of Illness | 2 | 2020 | 304 | 0.240 |
Why?
| | Health Services Needs and Demand | 2 | 2024 | 270 | 0.230 |
Why?
| | Data Collection | 2 | 2019 | 674 | 0.230 |
Why?
| | Troponin | 1 | 2023 | 51 | 0.200 |
Why?
| | Cardiovascular Agents | 1 | 2024 | 160 | 0.200 |
Why?
| | Quality Assurance, Health Care | 1 | 2024 | 324 | 0.190 |
Why?
| | Trust | 1 | 2022 | 123 | 0.180 |
Why?
| | Hospital Mortality | 2 | 2016 | 902 | 0.180 |
Why?
| | Frailty | 1 | 2024 | 169 | 0.180 |
Why?
| | Guideline Adherence | 1 | 2025 | 549 | 0.170 |
Why?
| | Survival Rate | 3 | 2024 | 1980 | 0.170 |
Why?
| | Home Nursing | 1 | 2020 | 25 | 0.170 |
Why?
| | Retrospective Studies | 12 | 2025 | 15628 | 0.170 |
Why?
| | BK Virus | 1 | 2019 | 14 | 0.160 |
Why?
| | Self Report | 1 | 2024 | 831 | 0.160 |
Why?
| | Thoracentesis | 1 | 2019 | 5 | 0.160 |
Why?
| | Medicare | 2 | 2015 | 747 | 0.160 |
Why?
| | Aged, 80 and over | 5 | 2024 | 7593 | 0.160 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 13 | 0.160 |
Why?
| | Family | 1 | 2023 | 667 | 0.150 |
Why?
| | Data Accuracy | 1 | 2019 | 63 | 0.150 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 41 | 0.150 |
Why?
| | Prospective Studies | 4 | 2024 | 7598 | 0.150 |
Why?
| | Viremia | 1 | 2019 | 138 | 0.150 |
Why?
| | Motion Pictures | 1 | 2019 | 20 | 0.150 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.150 |
Why?
| | Device Removal | 1 | 2020 | 138 | 0.150 |
Why?
| | Biomarkers | 2 | 2023 | 4172 | 0.150 |
Why?
| | Warfarin | 2 | 2021 | 149 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 118 | 0.150 |
Why?
| | Outpatients | 2 | 2023 | 393 | 0.150 |
Why?
| | Nurse Practitioners | 2 | 2019 | 135 | 0.140 |
Why?
| | Chronic Disease | 3 | 2022 | 1790 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 203 | 0.140 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 892 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 126 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2019 | 157 | 0.140 |
Why?
| | Spouses | 1 | 2018 | 105 | 0.140 |
Why?
| | Research Personnel | 1 | 2019 | 170 | 0.140 |
Why?
| | Organ Transplantation | 1 | 2020 | 248 | 0.130 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1580 | 0.130 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.130 |
Why?
| | Atropine | 1 | 2016 | 24 | 0.130 |
Why?
| | Loperamide | 1 | 2016 | 11 | 0.130 |
Why?
| | Antidiarrheals | 1 | 2016 | 15 | 0.130 |
Why?
| | Nursing Assessment | 1 | 2017 | 55 | 0.130 |
Why?
| | Pressure Ulcer | 1 | 2017 | 36 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 2019 | 211 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 279 | 0.130 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 5 | 0.130 |
Why?
| | Terminally Ill | 1 | 2016 | 37 | 0.130 |
Why?
| | Patient Care Management | 1 | 2016 | 56 | 0.130 |
Why?
| | Cause of Death | 1 | 2018 | 431 | 0.130 |
Why?
| | Follow-Up Studies | 6 | 2024 | 5139 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 34 | 0.130 |
Why?
| | Consumer Health Information | 1 | 2016 | 48 | 0.130 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 65 | 0.130 |
Why?
| | Prosthesis Design | 2 | 2016 | 309 | 0.130 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 54 | 0.130 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 390 | 0.130 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 36 | 0.120 |
Why?
| | Truth Disclosure | 1 | 2016 | 46 | 0.120 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 316 | 0.120 |
Why?
| | Mortality | 1 | 2018 | 357 | 0.120 |
Why?
| | Health Policy | 2 | 2020 | 388 | 0.120 |
Why?
| | Canada | 1 | 2017 | 421 | 0.120 |
Why?
| | Hospices | 1 | 2016 | 87 | 0.120 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 331 | 0.120 |
Why?
| | Drug Combinations | 1 | 2016 | 344 | 0.120 |
Why?
| | Social Security | 1 | 2015 | 5 | 0.120 |
Why?
| | Medical Indigency | 1 | 2015 | 11 | 0.120 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 29 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2021 | 780 | 0.120 |
Why?
| | Uncertainty | 1 | 2016 | 127 | 0.120 |
Why?
| | Sex Distribution | 1 | 2016 | 378 | 0.120 |
Why?
| | Patient Care Planning | 1 | 2016 | 155 | 0.120 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 202 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3292 | 0.120 |
Why?
| | Patient Selection | 1 | 2019 | 691 | 0.120 |
Why?
| | Health Care Costs | 1 | 2018 | 387 | 0.120 |
Why?
| | Workload | 1 | 2016 | 163 | 0.120 |
Why?
| | Multimedia | 1 | 2014 | 10 | 0.120 |
Why?
| | Factor X | 1 | 2014 | 27 | 0.110 |
Why?
| | Nurse's Role | 1 | 2016 | 151 | 0.110 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 86 | 0.110 |
Why?
| | Assisted Circulation | 1 | 2014 | 26 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 161 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 324 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 103 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 89 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 368 | 0.110 |
Why?
| | Family Relations | 1 | 2015 | 89 | 0.110 |
Why?
| | Disease Progression | 2 | 2025 | 2755 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1061 | 0.100 |
Why?
| | Population Surveillance | 1 | 2017 | 474 | 0.100 |
Why?
| | Patient Discharge | 2 | 2022 | 895 | 0.100 |
Why?
| | Risk | 1 | 2016 | 905 | 0.100 |
Why?
| | Sex Factors | 2 | 2016 | 2074 | 0.100 |
Why?
| | Prognosis | 5 | 2024 | 4031 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2016 | 447 | 0.100 |
Why?
| | Length of Stay | 2 | 2017 | 1210 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 259 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1264 | 0.100 |
Why?
| | Pain Management | 1 | 2016 | 363 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 414 | 0.100 |
Why?
| | Cohort Studies | 1 | 2023 | 5730 | 0.100 |
Why?
| | Program Evaluation | 1 | 2016 | 892 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 581 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2838 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 1008 | 0.090 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 891 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1312 | 0.090 |
Why?
| | Pilot Projects | 1 | 2016 | 1703 | 0.090 |
Why?
| | Health Behavior | 1 | 2016 | 764 | 0.090 |
Why?
| | Time Factors | 4 | 2024 | 6817 | 0.090 |
Why?
| | Motivation | 1 | 2015 | 571 | 0.080 |
Why?
| | Frail Elderly | 2 | 2024 | 126 | 0.080 |
Why?
| | Internet | 1 | 2014 | 656 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2719 | 0.080 |
Why?
| | Comorbidity | 3 | 2020 | 1618 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 1169 | 0.070 |
Why?
| | Incidence | 1 | 2014 | 2792 | 0.070 |
Why?
| | Colorado | 3 | 2025 | 4521 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2019 | 407 | 0.070 |
Why?
| | Academic Medical Centers | 2 | 2020 | 498 | 0.070 |
Why?
| | Disease Management | 2 | 2022 | 625 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2681 | 0.060 |
Why?
| | Postoperative Complications | 3 | 2024 | 2641 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5427 | 0.050 |
Why?
| | Michigan | 1 | 2024 | 108 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2025 | 153 | 0.050 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 63 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 233 | 0.050 |
Why?
| | Cannabinoids | 1 | 2025 | 161 | 0.050 |
Why?
| | Information Systems | 1 | 2023 | 61 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 13243 | 0.050 |
Why?
| | Comprehension | 1 | 2024 | 182 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 111 | 0.050 |
Why?
| | Death | 1 | 2022 | 119 | 0.050 |
Why?
| | Self Care | 1 | 2024 | 374 | 0.050 |
Why?
| | Consensus | 1 | 2024 | 685 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 34 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 210 | 0.040 |
Why?
| | Role | 1 | 2020 | 32 | 0.040 |
Why?
| | Hospitals, Community | 1 | 2020 | 50 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2024 | 657 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3301 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 65 | 0.040 |
Why?
| | Thromboembolism | 1 | 2021 | 119 | 0.040 |
Why?
| | Social Responsibility | 1 | 2020 | 51 | 0.040 |
Why?
| | Income | 1 | 2020 | 201 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 160 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 11 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 12 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 33 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 179 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 396 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 316 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 198 | 0.040 |
Why?
| | Survival | 1 | 2018 | 38 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 814 | 0.040 |
Why?
| | Walk Test | 1 | 2018 | 75 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 784 | 0.040 |
Why?
| | Viral Load | 1 | 2019 | 462 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 547 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 357 | 0.030 |
Why?
| | Equipment Design | 1 | 2019 | 526 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 411 | 0.030 |
Why?
| | Intraoperative Care | 1 | 2017 | 49 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2020 | 251 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 520 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 21555 | 0.030 |
Why?
| | Nurses | 1 | 2019 | 174 | 0.030 |
Why?
| | Hemorrhage | 1 | 2021 | 723 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 258 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1486 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 184 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 153 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 820 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 821 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1047 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 539 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 740 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1351 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1320 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 616 | 0.020 |
Why?
| | Stroke | 1 | 2021 | 1129 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2016 | 627 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1702 | 0.020 |
Why?
| | Telemedicine | 1 | 2020 | 852 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2369 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 1041 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1192 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1903 | 0.020 |
Why?
| | Child | 1 | 2022 | 22037 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|